VBI announces closing of public offering for gross proceeds of $42.9 million
VBI Vaccines announced the closing of its underwritten public offering of 26,800,000 common shares at a public offering price of US$1.40 per share, and partial exercise by underwriters of their option to purchase an additional 4,020,000 common shares. December 18, 2018